Olaparib is a compound that functions as a poly(ADP-ribose) polymerase (PARP) inhibitor, used in pharmaceutical manufacturing. It is a member of the N-acylpiperazine class and is employed as an antineoplastic agent, specifically as an apoptosis inducer via inhibition of NAD(+) ADP-ribosyltransferase.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 763113-22-0
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
pharmaceutical intermediate
4-{[4-fluoro-3-(piperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
pharmaceutical intermediate
4-{[4-fluoro-3-(4-nitrosopiperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
pharmaceutical intermediate
DL-methamphetamine
pharmaceutical raw material
Deacylated alfuzosin
pharmaceutical raw material
Enalaprilat
pharmaceutical raw material
(2S)-1-((2S)-2-(((1R)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid
pharmaceutical raw material
4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
FDLYAMZZIXQODN-UHFFFAOYSA-N
C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F